Business News • PR NewsWire • ICS 2018: Atlantic Therapeutics Exhibit New Data Demonstrating Comparable Efficacy, Increased Tolerability and Reduced Infection Risk of its Non-invasive Device Innovo® in Treating Stress Urinary Incontinence

ICS 2018: Atlantic Therapeutics Exhibit New Data Demonstrating Comparable Efficacy, Increased Tolerability and Reduced Infection Risk of its Non-invasive Device Innovo® in Treating Stress Urinary Incontinence

ICS 2018: Atlantic Therapeutics Exhibit New Data Demonstrating Comparable Efficacy, Increased Tolerability and Reduced Infection Risk of its Non-invasive Device Innovo® in Treating Stress Urinary Incontinence

PHILADELPHIA, Aug. 28, 2018 /PRNewswire/ -- Atlantic Therapeutics, a global manufacturer of innovative, garment-based pelvic floor muscle strengthening and nerve stimulation products, exhibits data highlighting comparable safety and efficacy of its INNOVO® therapy, an externally worn...

View More : https://www.prnewswire.com:443/news-releases/ics-2018-atlantic-therapeutics-exhibit-new-data-demonstrating-comparable-ef...

Releted News by prnewswire

NetCents Technology unterzeichnet Unternehmenslizenzvereinbarung für 28 karibische Länder und fügt Bitcoin Cash hinzu

Are You Underpaid? Survey Released With Robert Half 2019 Salary Guides Finds 46 Percent Of Workers Feel Shortchanged

U.S. News & World Report Adds User Ratings and Reviews to Best Colleges

Cambium Networks aderisce al progetto Express Wi-Fi di Facebook

KinoPharma and National Institutes for Quantum and Radiological Science and Technology Launch Collaborative Research Project for Exploring New Drug Development for Alzheimer's Disease

BanQu Launches Trailblazing Partnership with Anheuser-Busch InBev to Revolutionize Supply Chain Transparency in Zambia